This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page.(April 2017) (Learn how and when to remove this message)
This article contains content that is written like an advertisement. Please help improve it by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view.(January 2017) (Learn how and when to remove this message)
(Learn how and when to remove this message)
Impella is a family of medical devices used for temporary ventricular support in patients with depressed heart function. Some versions of the device can provide left heart support during other forms of mechanical circulatory support including ECMO and Centrimag.[1]
The device is approved for use in high-risk percutaneous coronary intervention (PCI) and cardiogenic shock following heart attack or open heart surgery and is placed through a peripheral artery.[2] From the peripheral artery it pumps blood to the left or right heart via the ascending aorta or pulmonary artery.
The Impella technology was acquired by Abiomed in 2005.[3] As of March 2019, the Impella series includes: the Impella 2.5, Impella 5.0/LD, Impella CP and Impella RP.[4][5][6]
^Shishehbor, MH; Moazami, N; Tong, MZ; Unai, S; Tang, WH; Soltesz, EG (April 2017). "Cardiogenic shock: From ECMO to Impella and beyond". Cleveland Clinic Journal of Medicine. 84 (4): 287–295. doi:10.3949/ccjm.84gr.17002. PMID 28388392.
^Bansal, A; Bhama, JK; Patel, R; et al. (2016). "Using the minimally invasive Impella 5.0 via the right subclavian artery cutdown for acute on chronic decompensated heart failure as a bridge to decision". Ochsner Journal. 16 (3): 210–216. PMC 5024800. PMID 27660567.
^"How Abiomed became a major medical device company". 10 October 2017.
^"Explore Impella® Technology for Heart Recovery".
^"Impella Ventricular Support Systems - P140003/S018". www.fda.gov. Archived from the original on 2018-04-24.
The Impella technology was acquired by Abiomed in 2005. As of March 2019, the Impella series includes: the Impella 2.5, Impella 5.0/LD, Impella CP and...
include the Impella 2.5, Impella 5.0, Impella CP with SmartAssist, Impella 5.5 with SmartAssist, Impella RP with SmartAssist and Impella Connect, which...
There are several types of left ventricular assist devices, with the Impella devices being some of the most common. This device is placed by a cardiac...
a blood vessel rather than through an incision) VADs such as the Impella 5.5, Impella RP, and others can be introduced to either the left or right ventricle...
further development of the device. In 2019, Abiomed was marketing the Impella Ventricular Support Systems, left-side heart pump models "intended to help...
Retrieved 15 March 2016. "ABIOMED | Impella®". Health, Center for Devices Radiological (3 June 2019). "Impella Ventricular Support Systems – P140003/S018"...
angioscopy and directional atherectomy. He is reported to be the first to use Impella heart support device and Drug-eluting stents, Bioresorbable stents and...
Nitin; Kini, Annapoorna S.; Sharma, Samin K. (25 April 2020). "Outcomes of Impella-supported high-risk nonemergent percutaneous coronary intervention in a...
of the heart by a percutaneous ventricular support device such as the Impella device can achieve this in two ways. First, the device is a continuous...
Global Information
